Abstract:AIM To evaluate bioequivalence of lansoprazole and its metabolites 5-hydroxy lansoprazole and lansoprazole sulphone in 22 healthy male vounteers after a single oral dose of 30 mg.METHODS LC:using Diamonsil C_(18) column(250 mm×2.1 mm,5 μm)with preliminary column Octadecy1 C_(18)(4.0 mm×3.05 mm);the mobile phase consiting of acetonitrile-2 mmol·L~(-1) ammonium acetate solution(60∶40,V/V);the flow rate was 0.2 mL·min~(-1);and the column temperature was 40℃.MS:using electrospray ionization (ESI),and selected ion mass spectral (m/z) 368.1/164.1 (lansoprazole),384.0/180.0 (5-hydroxylansoprazole),384/115.9 (lansoprazole sulphone),364.1/188.1(internal standard)to quantify.The plasma samples were treated with acetonitrile precipitation.RESULTS The pharmacokinetic parameters of lansoprazole (test) were:AUC:(12 989.16±13 356.96)μg·h·L~(-1),c_(max)(2 780±1 282)μg·L~(-1),t_(max):(1.73±0.74)h,T_(1/2):(2.74±2.01)h;5-hydroxy lansoprazole(test) were:AUC:(197.51±68.54)μg·h·L~(-1),c_(max):(73.45±39.09)μg·L~(-1),t_(max):(1.59±(0.76))h,T_(1/2):(3.26±1.97)h;lansoprazole sulphone (test) were:AUC:((1 496.74)±2 517.81)μg·h·L~(-1),c_(max):(160.75±146.12)μg·L~(-1),t_(max):(2.18±1.55)h,T_(1/2):(2.94±3.48)h.The pharmacokinetic parameters of lansoprazole (reference) were:AUC:(13 426.99±3 671.51)μg·h·L~(-1),c_(max):(2 945±(1 383))μg·L~(-1),t_(max):(1.90±0.63)h,T_(1/2):(2.53±2.06)h;5-hydroxy lansoprazole (reference) were:AUC:(211.77±(78.40))μg·h·L~(-1),c_(max):(77.70±43.78)μg·L~(-1),t_(max):(1.83±0.65),T_(1/2):(3.03±1.77)h;lansoprazole sulphone (reference) were:AUC:(1 510.80±2 525.48)μg·h·L~(-1),c_(max):(169.20±151.28)μg·L~(-1),t_(max):(2.27±1.37)h,T_(1/2):(2.64±2.96)h.There were no significant differences in all pharmacokinetic parameters between 2 capsules.(P>0.05).CONCLUSION The results of two one-side test show that 2 preparations are bioequivalent.

Study on bioequivalence of pravastatin sodium tablets in healthy volunteers

Study on bioequivalence of cilostazol table in healthy volunteers

Studies on Bioequivalence of Ramipril Capsule in Healthy Volunteers

Studies on the Bioequivalence of Lorazepam Tablet in Healthy Volunteers

Bioequivalence of Lansoprazole Enteric Caspsules in Healthy Volunteers

[Pharmacokinetics and Relative Bioavailability of Ziprasidone Tablets in Chinese Healthy Volunteers].

Bioequivalence of amlodipine besylate tablets in Chinese healthy volunteers

Bioequivalence Study of Voriconazole Tablet in Healthy Chinese Male Volunteers

Bioequivalence Evaluation of Two Rabeprazole Enteric Coated Formulations in Healthy Chinese Volunteers

Bioequivalence of Levodopa Tablets in Healthy Volunteers

Bioequivalence of Azithromycin Tablets in Healthy Volunteers

Bioequivalence of Pantoprazole Sodium Enteric-Coated Capsules in Human

Bioequivalence of Clarithromycin Dispersed Tablet in Health Volunteers

Bioequivalence Study Comparing a Generic and Innovator Drug of Rosuvastatin 20 mg

Pharmacokinetics and Bioequivalence of Two Formulations of Rosuvastatin Following Single‐dose Administration in Healthy Chinese Subjects Under Fasted and Fed Conditions

Bioequivalence of Valaciclovir Hydrochlordide Tablets in Healthy Volunteers

Studies on the bioequivalence of two sodium rebeprazole entric tablets in healthy volunteers

Bioequivalence of Two Domestic Praperations of Metformin Hydrochloride Entericcoated Capsules in Chinese Healthy Volunteers

Bioequivalence of lansoprazole and its metabolites

Relative bioavailability and bioequivalence of clopidogrel hydrogen sulfate tablets in healthy volunteers

Bioequivalence evaluation of domestic tablets and imported capsules of rivastigmine tartrate